{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:54:11Z","timestamp":1791942851982,"version":"4.3.4"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008790","name":"National Institute of Technology Rourkela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.abb.2020.108614","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T06:21:49Z","timestamp":1601446909000},"page":"108614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Sequence and structure-based peptides as potent amyloid inhibitors: A review"],"prefix":"10.1016","volume":"695","author":[{"given":"Amit","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-0629","authenticated-orcid":false,"given":"Nandini","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6880","key":"10.1016\/j.abb.2020.108614_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.abb.2020.108614_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/bp060374h","article-title":"Protein misfolding and aggregation","volume":"23","author":"Murphy","year":"2007","journal-title":"Biotechnol. Prog."},{"issue":"6968","key":"10.1016\/j.abb.2020.108614_bib4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.abb.2020.108614_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev-biochem-072611-130030","article-title":"Systemic amyloidoses","volume":"82","author":"Blancas-Mejia","year":"2013","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/jmbi.2000.3862","article-title":"Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain","volume":"300","author":"Krebs","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.abb.2020.108614_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1039\/df9531300077","article-title":"The globular-fibrous protein transformation","volume":"13","author":"Barbu","year":"1953","journal-title":"Discuss. Faraday Soc."},{"issue":"15","key":"10.1016\/j.abb.2020.108614_bib9","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1021\/bi00817a600","volume":"9","author":"Reisler","year":"1970","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0301-4622(75)80013-5","article-title":"Kinetics of the cooperative association of actin to actin filaments","volume":"3","author":"Wegner","year":"1975","journal-title":"Biophys. Chem."},{"issue":"4","key":"10.1016\/j.abb.2020.108614_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0022-5193(83)90244-8","article-title":"On one-dimensional nucleation and growth of \"living\" polymers I. Homogeneous nucleation","volume":"104","author":"Firestone","year":"1983","journal-title":"J.\u00a0Theor. Biol."},{"issue":"5012","key":"10.1016\/j.abb.2020.108614_bib12","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1675487","article-title":"Molecular biology of prion diseases","volume":"252","author":"Prusiner","year":"1991","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.abb.2020.108614_bib13","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5959","key":"10.1016\/j.abb.2020.108614_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1178250","article-title":"An analytical solution to the kinetics of breakable filament assembly","volume":"326","author":"Knowles","year":"2009","journal-title":"Science"},{"issue":"30","key":"10.1016\/j.abb.2020.108614_bib15","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1073\/pnas.0703306104","article-title":"Fiber-dependent amyloid formation as catalysis of an existing reaction pathway","volume":"104","author":"Ruschak","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","article-title":"Amyloid fibrillogenesis: themes and variations","volume":"10","author":"Rochet","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"14","key":"10.1016\/j.abb.2020.108614_bib17","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1021\/bi0160462","article-title":"Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis","volume":"41","author":"Padrick","year":"2002","journal-title":"Biochemistry"},{"issue":"25","key":"10.1016\/j.abb.2020.108614_bib18","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","article-title":"The fold of alpha-synuclein fibrils","volume":"105","author":"Vilar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.abb.2020.108614_bib19","doi-asserted-by":"crossref","first-page":"16742","DOI":"10.1073\/pnas.262663499","article-title":"A\u00a0structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR","volume":"99","author":"Petkova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.abb.2020.108614_bib20","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/anie.200604056","article-title":"IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes","volume":"46","author":"Yan","year":"2007","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"17","key":"10.1016\/j.abb.2020.108614_bib21","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1016\/j.febslet.2009.07.044","article-title":"Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts","volume":"583","author":"Wakabayashi","year":"2009","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/db06-0734","article-title":"Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets","volume":"56","author":"Ritzel","year":"2007","journal-title":"Diabetes"},{"issue":"23","key":"10.1016\/j.abb.2020.108614_bib23","doi-asserted-by":"crossref","first-page":"9460","DOI":"10.1073\/pnas.1102356108","article-title":"Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity","volume":"108","author":"Last","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5618","key":"10.1016\/j.abb.2020.108614_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jmbi.2001.5244","article-title":"Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity","volume":"315","author":"Kapurniotu","year":"2002","journal-title":"J.\u00a0Mol. Biol."},{"issue":"12","key":"10.1016\/j.abb.2020.108614_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/81937","article-title":"A\u00a0de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils","volume":"7","author":"Fezoui","year":"2000","journal-title":"Nat. Struct. Biol."},{"issue":"30","key":"10.1016\/j.abb.2020.108614_bib27","doi-asserted-by":"crossref","first-page":"31374","DOI":"10.1074\/jbc.M400348200","article-title":"Prefibrillar amyloid protein aggregates share common features of cytotoxicity","volume":"279","author":"Bucciantini","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"issue":"16","key":"10.1016\/j.abb.2020.108614_bib28","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1073\/pnas.89.16.7437","article-title":"Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4\/beta protein","volume":"89","author":"Knauer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib29","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1021\/jp9102993","article-title":"The thermodynamic stability of amyloid fibrils studied by differential scanning calorimetry","volume":"114","author":"Morel","year":"2010","journal-title":"J.\u00a0Phys. Chem. B"},{"issue":"43","key":"10.1016\/j.abb.2020.108614_bib30","doi-asserted-by":"crossref","first-page":"15806","DOI":"10.1073\/pnas.0604035103","article-title":"Characterization of the nanoscale properties of individual amyloid fibrils","volume":"103","author":"Smith","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6109","key":"10.1016\/j.abb.2020.108614_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib33","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.abb.2020.108614_bib34","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.abb.2020.108614_bib35","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.bpj.2012.04.050","article-title":"Fibrillar alpha-synuclein and huntingtin exon 1 assemblies are toxic to the cells","volume":"102","author":"Pieri","year":"2012","journal-title":"Biophys. J."},{"issue":"20","key":"10.1016\/j.abb.2020.108614_bib36","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models","volume":"28","author":"Karpinar","year":"2009","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.abb.2020.108614_bib37","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In\u00a0vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.abb.2020.108614_bib38","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.abb.2020.108614_bib39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.abb.2020.108614_bib40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib41","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J.\u00a0Neurosci."},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib42","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"6880","key":"10.1016\/j.abb.2020.108614_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2011.11.008","article-title":"Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures","volume":"51","author":"Ferreira","year":"2012","journal-title":"Cell Calcium"},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib45","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00109-008-0391-6","article-title":"Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice","volume":"86","author":"Eckert","year":"2008","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.abb.2020.108614_bib46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.abb.2020.108614_bib47","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of alpha-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"issue":"5697","key":"10.1016\/j.abb.2020.108614_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1101262","article-title":"Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation","volume":"306","author":"Gestwicki","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11030-006-9035-3","article-title":"Interrogating the druggable genome with structural informatics","volume":"10","author":"Hambly","year":"2006","journal-title":"Mol. Divers."},{"issue":"7172","key":"10.1016\/j.abb.2020.108614_bib50","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature06526","article-title":"Reaching for high-hanging fruit in drug discovery at protein-protein interfaces","volume":"450","author":"Wells","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nbt1273","article-title":"Structure-based maximal affinity model predicts small-molecule druggability","volume":"25","author":"Cheng","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.abb.2020.108614_bib52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jmgm.2005.08.002","article-title":"Exploring protein-ligand recognition with Binding MOAD","volume":"24","author":"Smith","year":"2006","journal-title":"J.\u00a0Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.abb.2020.108614_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","article-title":"REVIEW: curcumin and Alzheimer's disease","volume":"16","author":"Hamaguchi","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.abb.2020.108614_bib54","doi-asserted-by":"crossref","first-page":"350516","DOI":"10.1155\/2014\/350516","article-title":"Resveratrol as a therapeutic agent for Alzheimer's disease","volume":"2014","author":"Ma","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.abb.2020.108614_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nchem.2476","article-title":"Expanding the chemical toolbox for the synthesis of large and uniquely modified proteins","volume":"8","author":"Bondalapati","year":"2016","journal-title":"Nat. Chem."},{"issue":"24","key":"10.1016\/j.abb.2020.108614_bib56","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1021\/jo4020722","article-title":"Diversity-oriented approaches to unusual alpha-amino acids and peptides: step economy, atom economy, redox economy, and beyond","volume":"78","author":"Kotha","year":"2013","journal-title":"J.\u00a0Org. Chem."},{"issue":"22","key":"10.1016\/j.abb.2020.108614_bib57","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1021\/ol902131n","article-title":"A\u00a0one-pot approach to neoglycopeptides using orthogonal native chemical ligation and click chemistry","volume":"11","author":"Lee","year":"2009","journal-title":"Org. Lett."},{"issue":"14","key":"10.1016\/j.abb.2020.108614_bib58","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1039\/C5CS00889A","article-title":"Fmoc-modified amino acids and short peptides: simple bio-inspired building blocks for the fabrication of functional materials","volume":"45","author":"Tao","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"10","key":"10.1016\/j.abb.2020.108614_bib59","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.abb.2020.108614_bib60","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/syn.20957","article-title":"Alzheimer's disease: beta-amyloid plaque formation in human brain","volume":"65","author":"Seeman","year":"2011","journal-title":"Synapse"},{"issue":"5300","key":"10.1016\/j.abb.2020.108614_bib61","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.275.5300.630","article-title":"Alzheimer's disease: genotypes, phenotypes, and treatments","volume":"275","author":"Selkoe","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib62","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000100355","article-title":"Amyloid-beta aggregation","volume":"4","author":"Finder","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"9","key":"10.1016\/j.abb.2020.108614_bib64","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/bi802046n","article-title":"Structural characterization of a soluble amyloid beta-peptide oligomer","volume":"48","author":"Yu","year":"2009","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1110\/ps.0225703","article-title":"Enhanced correction methods for hydrogen exchange-mass spectrometric studies of amyloid fibrils","volume":"12","author":"Kheterpal","year":"2003","journal-title":"Protein Sci."},{"issue":"7000","key":"10.1016\/j.abb.2020.108614_bib66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"issue":"2\u20133","key":"10.1016\/j.abb.2020.108614_bib67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/jsbi.2000.4288","article-title":"The Alzheimer's peptide a beta adopts a collapsed coil structure in water","volume":"130","author":"Zhang","year":"2000","journal-title":"J.\u00a0Struct. Biol."},{"issue":"18","key":"10.1016\/j.abb.2020.108614_bib68","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"issue":"19","key":"10.1016\/j.abb.2020.108614_bib69","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1074\/jbc.272.19.12601","article-title":"Controlling amyloid beta-peptide fibril formation with protease-stable ligands","volume":"272","author":"Tjernberg","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"issue":"15","key":"10.1016\/j.abb.2020.108614_bib70","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.271.15.8545","article-title":"Arrest of beta-amyloid fibril formation by a pentapeptide ligand","volume":"271","author":"Tjernberg","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib71","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1006\/bbrc.1996.1413","article-title":"Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation","volume":"226","author":"Soto","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"62","key":"10.1016\/j.abb.2020.108614_bib72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-3-7091-6139-5_27","article-title":"Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease?","author":"Permanne","year":"2002","journal-title":"J.\u00a0Neural. Transm. Suppl."},{"issue":"7","key":"10.1016\/j.abb.2020.108614_bib73","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy","volume":"4","author":"Soto","year":"1998","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nbd.2004.08.007","article-title":"In\u00a0vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour","volume":"17","author":"Datki","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib75","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-2010-1297","article-title":"LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity","volume":"19","author":"Granic","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"16","key":"10.1016\/j.abb.2020.108614_bib76","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1074\/jbc.M113.537472","article-title":"Computational and experimental studies on beta-sheet breakers targeting Abeta1-40 fibrils","volume":"289","author":"Minicozzi","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"issue":"26","key":"10.1016\/j.abb.2020.108614_bib77","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1021\/bi002734u","article-title":"Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF","volume":"40","author":"Lowe","year":"2001","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.abb.2020.108614_bib78","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/bi701415b","article-title":"Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide","volume":"47","author":"Austen","year":"2008","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib79","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/bm401795e","article-title":"Study on the efficiency and interaction mechanism of a decapeptide inhibitor of beta-amyloid aggregation","volume":"15","author":"Liu","year":"2014","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.abb.2020.108614_bib80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/13506120108993819","article-title":"Characterization of cholyl-leu-val-phe-phe-ala-OH as an inhibitor of amyloid beta-peptide polymerization","volume":"8","author":"Findeis","year":"2001","journal-title":"Amyloid"},{"issue":"21","key":"10.1016\/j.abb.2020.108614_bib81","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1021\/bi982824n","article-title":"Modified-peptide inhibitors of amyloid beta-peptide polymerization","volume":"38","author":"Findeis","year":"1999","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.0.CO;2-E","article-title":"Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma","volume":"39","author":"Poduslo","year":"1999","journal-title":"J.\u00a0Neurobiol."},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-3011.2003.21028.x","article-title":"Practical assay and molecular mechanism of aggregation inhibitors of beta-amyloid","volume":"61","author":"Akikusa","year":"2003","journal-title":"J.\u00a0Pept. Res."},{"issue":"24","key":"10.1016\/j.abb.2020.108614_bib84","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1021\/bi050225s","article-title":"Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context","volume":"44","author":"Gibson","year":"2005","journal-title":"Biochemistry"},{"issue":"42","key":"10.1016\/j.abb.2020.108614_bib85","doi-asserted-by":"crossref","first-page":"40730","DOI":"10.1074\/jbc.M305466200","article-title":"Targeted control of kinetics of beta-amyloid self-association by surface tension-modifying peptides","volume":"278","author":"Kim","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.abb.2020.108614_bib86","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/bip.21151","article-title":"Rationally designed dehydroalanine (DeltaAla)-containing peptides inhibit amyloid-beta (Abeta) peptide aggregation","volume":"91","author":"Rangachari","year":"2009","journal-title":"Biopolymers"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib87","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1399-3011.2004.00156.x","article-title":"Inhibition of beta-amyloid toxicity by short peptides containing N-methyl amino acids","volume":"63","author":"Cruz","year":"2004","journal-title":"J.\u00a0Pept. Res."},{"issue":"37","key":"10.1016\/j.abb.2020.108614_bib88","doi-asserted-by":"crossref","first-page":"34874","DOI":"10.1074\/jbc.M212694200","article-title":"Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide","volume":"278","author":"Chalifour","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"32","key":"10.1016\/j.abb.2020.108614_bib89","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/bi060837s","article-title":"N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure","volume":"45","author":"Kokkoni","year":"2006","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib90","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1021\/bc025526i","article-title":"Multiple-peptide conjugates for binding beta-amyloid plaques of Alzheimer's disease","volume":"14","author":"Zhang","year":"2003","journal-title":"Bioconjugate Chem."},{"issue":"9","key":"10.1016\/j.abb.2020.108614_bib91","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cmdc.200900191","article-title":"Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors","volume":"4","author":"Grillo-Bosch","year":"2009","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.abb.2020.108614_bib92","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.peptides.2010.06.033","article-title":"Development of retro-inverso peptides as anti-aggregation drugs for beta-amyloid in Alzheimer's disease","volume":"31","author":"Matharu","year":"2010","journal-title":"Peptides"},{"issue":"15","key":"10.1016\/j.abb.2020.108614_bib93","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/bi100144m","article-title":"Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease","volume":"49","author":"Taylor","year":"2010","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054769","article-title":"A\u00a0novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe\/PS1DeltaE9 mouse model of Alzheimer's disease","volume":"8","author":"Parthsarathy","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2009.01.090","article-title":"Design and biological activity of beta-sheet breaker peptide conjugates","volume":"380","author":"Rocha","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.abb.2020.108614_bib96","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1016\/j.bmcl.2011.07.111","article-title":"Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Abeta(1)-(4)(2) fibril formation in\u00a0vitro","volume":"21","author":"Wei","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib97","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/psc.1109","article-title":"Design and synthesis of new trehalose-conjugated pentapeptides as inhibitors of Abeta(1-42) fibrillogenesis and toxicity","volume":"15","author":"De Bona","year":"2009","journal-title":"J.\u00a0Pept. Sci."},{"issue":"16","key":"10.1016\/j.abb.2020.108614_bib98","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1016\/j.bmc.2010.06.087","article-title":"In\u00a0vitro ADMET and physicochemical investigations of poly-N-methylated peptides designed to inhibit Abeta aggregation","volume":"18","author":"Bose","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.abb.2020.108614_bib99","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1039\/C3TB21483D","article-title":"Fluorinated beta-sheet breaker peptides","volume":"2","author":"Loureiro","year":"2014","journal-title":"J.\u00a0Mater. Chem. B"},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib100","article-title":"The effect of terminal groups and halogenation of KLVFF peptide on its activity as an inhibitor of beta-amyloid aggregation","volume":"26","author":"Samani","year":"2020","journal-title":"J.\u00a0Pept. Sci."},{"issue":"10","key":"10.1016\/j.abb.2020.108614_bib101","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/cn900019r","article-title":"Effects of peptides derived from terminal modifications of the abeta central hydrophobic core on abeta fibrillization","volume":"1","author":"Bett","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib102","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/chem.201404562","article-title":"Gold-nanoparticle-based multifunctional amyloid-beta inhibitor against Alzheimer's disease","volume":"21","author":"Gao","year":"2015","journal-title":"Chemistry"},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib103","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.nano.2016.10.006","article-title":"Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Abeta peptide","volume":"13","author":"Gregori","year":"2017","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib104","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41467-018-04255-z","article-title":"A\u00a0self-destructive nanosweeper that captures and clears amyloid beta-peptides","volume":"9","author":"Luo","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.abb.2020.108614_bib105","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1021\/acsami.5b00915","article-title":"Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid beta-protein fibrillation and cytotoxicity","volume":"7","author":"Xiong","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.abb.2020.108614_bib106","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1021\/acschemneuro.6b00175","article-title":"Natural tripeptide-based inhibitor of multifaceted amyloid beta toxicity","volume":"7","author":"Rajasekhar","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.abb.2020.108614_bib107","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1038\/srep08139","article-title":"Rationally designed peptidomimetic modulators of abeta toxicity in Alzheimer's disease","volume":"5","author":"Rajasekhar","year":"2015","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.abb.2020.108614_bib108","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1074\/jbc.M801383200","article-title":"Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding","volume":"283","author":"Apostolidou","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib109","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ar200189b","article-title":"Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective","volume":"45","author":"Brender","year":"2012","journal-title":"Acc. Chem. Res."},{"issue":"8","key":"10.1016\/j.abb.2020.108614_bib110","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.abb.2020.108614_bib111","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1097-0282(2001)60:6<438::AID-BIP10182>3.0.CO;2-A","article-title":"Amyloidogenicity and cytotoxicity of islet amyloid polypeptide","volume":"60","author":"Kapurniotu","year":"2001","journal-title":"Biopolymers"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib112","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.abb.2020.108614_bib113","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.chembiol.2005.05.010","article-title":"Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid- core-containing hexapeptide","volume":"12","author":"Tatarek-Nossol","year":"2005","journal-title":"Chem. Biol."},{"issue":"4","key":"10.1016\/j.abb.2020.108614_bib114","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","article-title":"Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties","volume":"295","author":"Tenidis","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"issue":"13","key":"10.1016\/j.abb.2020.108614_bib115","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib116","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-2836(02)00164-X","article-title":"Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis","volume":"318","author":"Scrocchi","year":"2002","journal-title":"J.\u00a0Mol. Biol."},{"issue":"31","key":"10.1016\/j.abb.2020.108614_bib117","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1002\/anie.200353565","article-title":"Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid","volume":"43","author":"Gilead","year":"2004","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"37","key":"10.1016\/j.abb.2020.108614_bib118","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A\u00a0single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"26","key":"10.1016\/j.abb.2020.108614_bib119","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1039\/c3cc38982k","article-title":"Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization","volume":"49","author":"Mishra","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.abb.2020.108614_bib120","first-page":"9062032","article-title":"A\u00a0novel pentapeptide inhibitor reduces amyloid deposit formation by direct interaction with hIAPP","volume":"2019","author":"Shi","year":"2019","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.abb.2020.108614_bib121","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-8630-9_2","article-title":"Development of peptide-based inhibitors of amylin aggregation employing aromatic and electrostatic repulsion","volume":"1824","author":"Profit","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.abb.2020.108614_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","article-title":"The biochemistry of Parkinson's disease","volume":"74","author":"Cookson","year":"2005","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.abb.2020.108614_bib123","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.abb.2020.108614_bib124","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"6645","key":"10.1016\/j.abb.2020.108614_bib125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.abb.2020.108614_bib126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.abb.2020.108614_bib127","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A\u00a0hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"issue":"32","key":"10.1016\/j.abb.2020.108614_bib128","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/bi00032a006","article-title":"Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic","volume":"34","author":"Iwai","year":"1995","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1471-4159.2001.00408.x","article-title":"Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity","volume":"78","author":"Bodles","year":"2001","journal-title":"J.\u00a0Neurochem."},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib130","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","article-title":"A\u00a0strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders","volume":"18","author":"El-Agnaf","year":"2004","journal-title":"Faseb. J."},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/302486","article-title":"Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein","volume":"65","author":"Athanassiadou","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"1\u20132","key":"10.1016\/j.abb.2020.108614_bib132","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(98)01419-7","article-title":"Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.abb.2020.108614_bib133","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in alpha-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib134","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9","article-title":"Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism","volume":"46","author":"Markopoulou","year":"1999","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib136","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.52.3.651","article-title":"Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance?","volume":"52","author":"Papadimitriou","year":"1999","journal-title":"Neurology"},{"issue":"5321","key":"10.1016\/j.abb.2020.108614_bib137","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib138","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.67","article-title":"Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation","volume":"49","author":"Spira","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.abb.2020.108614_bib139","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2003.12.077","article-title":"Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue","volume":"359","author":"Bodles","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"25","key":"10.1016\/j.abb.2020.108614_bib140","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1021\/ja075356q","article-title":"Design of an N-methylated peptide inhibitor of alpha-synuclein aggregation guided by solid-state NMR","volume":"130","author":"Madine","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.abb.2020.108614_bib141","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbrc.2009.07.083","article-title":"beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein","volume":"387","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib142","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbrc.2011.04.034","article-title":"The hexapeptide PGVTAV suppresses neurotoxicity of human alpha-synuclein aggregates","volume":"408","author":"Choi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013863","article-title":"Inhibiting alpha-synuclein oligomerization by stable cell-penetrating beta-synuclein fragments recovers phenotype of Parkinson's disease model flies","volume":"5","author":"Shaltiel-Karyo","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib144","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3390\/ijms14022590","article-title":"Partial peptide of alpha-synuclein modified with small-molecule inhibitors specifically inhibits amyloid fibrillation of alpha-synuclein","volume":"14","author":"Yoshida","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1074-5521(03)00022-X","article-title":"Conformational restriction via cyclization in beta-amyloid peptide Abeta(1-28) leads to an inhibitor of Abeta(1-28) amyloidogenesis and cytotoxicity","volume":"10","author":"Kapurniotu","year":"2003","journal-title":"Chem. Biol."},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib146","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1021\/bc900281b","article-title":"Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation","volume":"20","author":"Ouberai","year":"2009","journal-title":"Bioconjugate Chem."},{"issue":"31","key":"10.1016\/j.abb.2020.108614_bib147","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1002\/anie.201405109","article-title":"Rational design and identification of a non-peptidic aggregation inhibitor of amyloid-beta based on a pharmacophore motif obtained from cyclo[-Lys-Leu-Val-Phe-Phe-]","volume":"53","author":"Arai","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"17","key":"10.1016\/j.abb.2020.108614_bib148","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/cbic.201402430","article-title":"A\u00a0cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-beta oligomers","volume":"15","author":"Arai","year":"2014","journal-title":"Chembiochem"},{"issue":"15","key":"10.1016\/j.abb.2020.108614_bib149","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.bmcl.2015.05.027","article-title":"Covalent modifier-type aggregation inhibitor of amyloid-beta based on a cyclo-KLVFF motif","volume":"25","author":"Kino","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"28","key":"10.1016\/j.abb.2020.108614_bib150","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1021\/bi002416v","article-title":"Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues","volume":"40","author":"Gordon","year":"2001","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.abb.2020.108614_bib151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1399-3011.2002.11002.x","article-title":"Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis","volume":"60","author":"Gordon","year":"2002","journal-title":"J.\u00a0Pept. Res."},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib152","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/bi0259857","article-title":"Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions","volume":"42","author":"Gordon","year":"2003","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.abb.2020.108614_bib153","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/ja0600678","article-title":"Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids","volume":"128","author":"Etienne","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.abb.2020.108614_bib154","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01681","article-title":"Designed alpha-sheet peptides inhibit amyloid formation by targeting toxic oligomers","volume":"3","author":"Hopping","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.abb.2020.108614_bib155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2019.00054","article-title":"Structure-based peptide inhibitor design of amyloid-beta aggregation","volume":"12","author":"Lu","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"16","key":"10.1016\/j.abb.2020.108614_bib156","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/1873-3468.12261","article-title":"Peptide Inhibitors of the amyloidogenesis of IAPP: verification of the hairpin-binding geometry hypothesis","volume":"590","author":"Sivanesam","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2020.108614_bib157","doi-asserted-by":"crossref","first-page":"40095","DOI":"10.1038\/srep40095","article-title":"Disaggregation of amylin aggregate by novel conformationally restricted aminobenzoic acid containing alpha\/beta and alpha\/gamma hybrid peptidomimetics","volume":"7","author":"Paul","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.abb.2020.108614_bib158","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nchembio.193","article-title":"Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models","volume":"5","author":"Kritzer","year":"2009","journal-title":"Nat. Chem. Biol."},{"issue":"40","key":"10.1016\/j.abb.2020.108614_bib159","doi-asserted-by":"crossref","first-page":"14236","DOI":"10.1002\/chem.201601830","article-title":"Self-assembled cyclic d,l-alpha-Peptides as generic conformational inhibitors of the alpha-synuclein aggregation and toxicity: in\u00a0vitro and mechanistic studies","volume":"22","author":"Chemerovski-Glikman","year":"2016","journal-title":"Chemistry"},{"key":"10.1016\/j.abb.2020.108614_bib160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.abb.2017.09.015","article-title":"The inhibitory effects of biomimetically designed peptides on alpha-synuclein aggregation","volume":"634","author":"Rezaeian","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.abb.2020.108614_bib161","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46775","article-title":"Inhibition of synucleinopathic seeding by rationally designed inhibitors","volume":"9","author":"Sangwan","year":"2020","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.abb.2020.108614_bib162","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1568026024607508","article-title":"Peptide inhibitors of beta amyloid aggregation","volume":"2","author":"Findeis","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.abb.2020.108614_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128553","article-title":"Preclinical pharmacokinetic studies of the tritium labelled D-enantiomeric peptide D3 developed for the treatment of alzheimer s disease","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.abb.2020.108614_bib165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","article-title":"Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease","volume":"34","author":"Handattu","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.abb.2020.108614_bib167","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/ja310064v","article-title":"In\u00a0vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-alpha-peptide architecture","volume":"135","author":"Richman","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"17","key":"10.1016\/j.abb.2020.108614_bib168","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.1976.03260430034020","article-title":"Pharmacokinetics in clinical practice. I. Concepts","volume":"235","author":"Gibaldi","year":"1976","journal-title":"J.\u00a0Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.abb.2020.108614_bib169","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11095-015-1791-2","article-title":"Pharmacokinetic properties of a novel D-peptide developed to be therapeutically active against toxic beta-amyloid oligomers","volume":"33","author":"Leithold","year":"2016","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"5","key":"10.1016\/j.abb.2020.108614_bib170","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s00500-019-04087-z","article-title":"Sequence- and structure-based prediction of amyloidogenic regions in proteins","volume":"24","author":"Bouziane","year":"2020","journal-title":"Soft Comput."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120306238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120306238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:16:17Z","timestamp":1757744177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986120306238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":168,"alternative-id":["S0003986120306238"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2020.108614","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequence and structure-based peptides as potent amyloid inhibitors: A review","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2020.108614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108614"}}